ES2054840T3 - Forma galenica a base de extracto seco de plantas. - Google Patents

Forma galenica a base de extracto seco de plantas.

Info

Publication number
ES2054840T3
ES2054840T3 ES88400760T ES88400760T ES2054840T3 ES 2054840 T3 ES2054840 T3 ES 2054840T3 ES 88400760 T ES88400760 T ES 88400760T ES 88400760 T ES88400760 T ES 88400760T ES 2054840 T3 ES2054840 T3 ES 2054840T3
Authority
ES
Spain
Prior art keywords
active principle
plant extract
form based
solubilisation
suspension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88400760T
Other languages
English (en)
Inventor
Pierre Dupinay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Application granted granted Critical
Publication of ES2054840T3 publication Critical patent/ES2054840T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

EL PRESENTE INVENTO CONCIERNE A UN PROCESO DE PREPARACION DE UNA FORMULA GALENICA QUE SE PRESENTA EN FORMA DE GRANOS HIDROSOLUBLES Y FORMULA GALENICA EN PARTICULAR A BASE DE UN EXTRACTO SECO DE GINKGO BILOBA. EL PROCESO SEGUN EL PRESENTE INVENTO SE CARACTERIZA POR LA REALIZACION DE LAS OPERACIONES SUCESIVAS SIGUIENTES: - HUMECTACION Y / O SOLUBILIZACION DEL PRINCIPIO ACTIVO POR MEDIO DE UN SOVENTE ALCOHOLICO O HIDROALCOHOLICO; - ADICION, AL PRINCIPIO ACTIVO HUMECTADO O SOLUBILIZADO, DE UN AGENTE TENSOACTIVO Y EVENTUALMENTE UN ELASTICO; - HOMOGENEIZACION DE LA SUSPENSION O SOLUCION ASI OBTENIDA, O SOLUBILIZACION; - MEZCLA DE DICHA SUSPENSION O SOLUCION CON UN SOPORTE HIDROSOLUBLE FARMACEUTICAMENTE ACEPTABLE Y COMPATIBLE CON EL PRINCIPIO ACTIVO; - GRANULACION DE DICHA MEZCLA Y EVAPORACION DEL SOLVENTE POR SECADO.
ES88400760T 1987-04-03 1988-03-29 Forma galenica a base de extracto seco de plantas. Expired - Lifetime ES2054840T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8704700A FR2613223B1 (fr) 1987-04-03 1987-04-03 Forme galenique se presentant sous la forme de grains hydrosolubles, en particulier a base d'un extrait sec de ginkgo biloba, et son procede de preparation

Publications (1)

Publication Number Publication Date
ES2054840T3 true ES2054840T3 (es) 1994-08-16

Family

ID=9349759

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88400760T Expired - Lifetime ES2054840T3 (es) 1987-04-03 1988-03-29 Forma galenica a base de extracto seco de plantas.

Country Status (5)

Country Link
EP (1) EP0290299B1 (es)
AT (1) ATE86477T1 (es)
DE (1) DE3878978T2 (es)
ES (1) ES2054840T3 (es)
FR (1) FR2613223B1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2634376B1 (fr) * 1988-07-21 1992-04-17 Farmalyoc Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
JP2818220B2 (ja) * 1988-11-04 1998-10-30 フロイント産業株式会社 食品用の含水有機溶剤抽出物含有組成物および医薬用の含水有機溶剤抽出物含有組成物、並びにそれらの製造方法
FR2657258A1 (fr) * 1990-01-19 1991-07-26 Farmalyoc Nouvelle forme unitaire, solide et poreuse comprenant des particules sous forme de perles ainsi que sa preparation.
US5417985A (en) * 1989-07-20 1995-05-23 Farmalyoc Solid and porous single dosage form comprising particles in the form of beads and its preparation
DE9320586U1 (de) * 1993-10-11 1994-10-13 Hgb Pharma Service Gmbh Topische Formulierung eines solubilisierten Ginkgo-biloba-Extraktes
FR2790668B1 (fr) * 1999-03-12 2002-07-26 D B F Granules contenant une substance vegetale et leur procede de preparation
WO2000069414A2 (fr) * 1999-05-17 2000-11-23 D.B.F. Granules contenant une substance vegetale et leur procede de preparation
FR2821552B1 (fr) * 2001-03-01 2004-07-09 Cll Pharma Procede pour rendre hydrosoluble un principe actif naturellement peu ou pas soluble dans l'eau et ses utilisations
TW200403075A (en) * 2002-05-29 2004-03-01 Akzo Nobel Nv Progestagenic dosage units
WO2005034923A1 (en) 2003-10-10 2005-04-21 Ethypharm Sustained-release microgranules containing gingko biloba extract and the process for manufacturing these
FR2938430B1 (fr) * 2008-11-14 2011-05-20 Debregeas Et Associes Pharma Granules a base de plantes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR840092A (fr) * 1937-12-24 1939-04-18 Procédé et appareil perfectionnés pour extraire et fixer à l'état de poudre sèche les principes actifs provenant de la matière organique vivante ou de produits fragiles de la chimie organique
DE1767098C2 (de) * 1968-03-29 1973-01-04 Dr. Willmar Schwabe Gmbh, 7500 Karlsruhe-Durlach Verfahren zur Gewinnung eines vasoaktiven Arzneimittels aus den Blättern von Ginkgo biloba
DE1792525A1 (de) * 1968-09-13 1972-01-27 Hag Ag Verfahren zur Herstellung poroeser und koerniger Aggregate aus pulverfoermigem Material
US4344934A (en) * 1978-11-20 1982-08-17 American Home Products Corporation Therapeutic compositions with enhanced bioavailability
FR2583640A1 (fr) * 1985-06-24 1986-12-26 Berdal Pascal Compositions pharmaceutiques a visee vasculotrope et antisclereuse

Also Published As

Publication number Publication date
FR2613223B1 (fr) 1991-09-13
DE3878978D1 (de) 1993-04-15
FR2613223A1 (fr) 1988-10-07
DE3878978T2 (de) 1993-07-15
EP0290299B1 (fr) 1993-03-10
ATE86477T1 (de) 1993-03-15
EP0290299A1 (fr) 1988-11-09

Similar Documents

Publication Publication Date Title
ES2050340T3 (es) Preparados de pancreatina.
ES2054840T3 (es) Forma galenica a base de extracto seco de plantas.
US6207164B1 (en) Process for the preparation of a stable, homogeneous, extract free or nearly free from secondary reaction products
HUP9902165A2 (hu) Nagy fajlagos felületű D-mannit, eljárás előállítására, valamint ilyen mannitot tartalmazó szilárd kompozíciók
ATA457772A (de) Verfahren zur herstellung von festen, denwirkstoff langsam abgebenden pharmazeutischen zubereitungen
DE68914858D1 (de) Verfahren zur Herstellung von Formaldehyd und dessen Derivaten.
DK0388954T3 (da) Frysetørrede polymerdispersioner og anvendelsen deraf til fremstilling af farmaceutiske præparater m ed langvarig frigivelse
DE59305700D1 (de) Verfahren zur Herstellung von festen pharmazeutischen Retardformen
FR2619718B1 (fr) Nouvelles formes galeniques de beta-2-mimetiques pour administration par voie per- et sublinguale
NL175383C (nl) Werkwijze ter bereiding van een vaso-actief mengsel van werkzame stoffen uit de bladeren van ginkgo biloba en bereiding van geneeskundige preparaten daaruit.
DE3767998D1 (de) Clodronat-haltige arzneimittel und verfahren zur herstellung derselben.
RU93004547A (ru) Фармацевтический состав на основе tanacetum partheniom, способ его получения и лекарственное средство на его основе
MX9300265A (es) Composicion activa farmaceuticamente compuesta de tanacetum parthenium y derivados partenoliticos de sesquiterpen-lactona y procedimiento para su preparacion.
NL7602062A (nl) Werkwijze voor het bereiden van opslag-stabiele dis- persies van in water oplosbare verbindingen, werk- wijze voor het appreteren van natuurlijke en/of synthetische organische materialen, alsmede de behandelde gevormde materialen.
EP0417588A3 (en) Process for the preparation of a complexed drug
FR2609895B1 (fr) Nouvelles formes galeniques d'allergenes pour administration par voie per- et sub-linguale
IE39246B1 (en) Process for preparing a purified extract of quillata bark
ATE266997T1 (de) Verfahren zum herstellen von kapseln und tabletten aus naturstoffen pflanzlichen ursprungs
NL7412421A (nl) Werkwijze voor de bereiding van 2,5-digesubsti- tueerde benzamiden, de additiezouten ervan met farmaceutisch aanvaardbare anorganische en or- ganische zuren en de quaternaire ammoniumzouten ervan, alsmede werkwijze voor de bereiding van farmaceutische preparaten en de zo gevormde preparaten.
NL148602B (nl) Werkwijze voor het bereiden van een farmaceutisch preparaat waarin op de 5-plaats gesubstitueerde 1-alkyl-2-nitro-imidazoolderivaten zijn opgenomen, alsmede gevormd preparaat en werkwijze voor het bereiden van deze verbindingen.
NL181009C (nl) Werkwijze voor het bereiden van een farmaceutisch preparaat met antibacteriele werking, alsmede werkwijze voor het bereiden van een 7beta-acylamino-7alfa-methoxy-3-(1-alkyl-1h-tetrazool-5-yl)thiomethyl-3-cefem-4-carbonzuur derivaat.
NL180665C (nl) Werkwijze voor de bereiding of vervaardiging van een farmaceutisch preparaat met antibacteriele werking, alsmede werkwijze voor het bereiden van een 7-acylamino-3-heterocyclylthiomethyl-3-cefem-4-carbonzuur derivaat.
ATE65026T1 (de) Verfahren zum gleichzeitigen trocknen und granulieren von extraktstoffen aus enteiweisstem kaelberblut, nach diesem verfahren erhaltenes granulat und dessen verwendung zur herstellung von pharmazeutischen praeparaten.
ATA1015273A (de) Verfahren zur herstellung von neuen (1,4) ditihiino (2,3-c) pyrrolderivaten und von deren saureadditionssalzen
NL159378B (nl) Werkwijze voor het bereiden van 2-aminoalkyl-6-methyl-7-nitro-1,2,3,4-tetrahydrochinolinen, werkwijze voor het bereiden van een farmaceutisch preparaat, alsmede gevormd farmaceutisch preparaat.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 290299

Country of ref document: ES